Padmanabh P. Bhatt - 28 Jan 2025 Form 4/A - Amendment Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Signature
/s/ Timothy C. Dec, as attorney-in-fact
Issuer symbol
SUPN
Transactions as of
28 Jan 2025
Net transactions value
$0
Form type
4/A - Amendment
Filing time
05 Feb 2025, 16:33:33 UTC
Date Of Original Report
29 Jan 2025
Previous filing
29 Jan 2025
Next filing
05 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SUPN Common Stock 10,149 28 Jan 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Employee Stock Option (Right to Buy) Options Exercise $0 -700 -4.9% $0.000000 13,727 28 Jan 2025 Common Stock 700 $29.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested in four equal installments beginning on February 19, 2022.

Remarks:

The original Form 4, filed on January 29, 2025, incorrectly reported the number of derivative securities beneficially owned following the reported transaction in Table II, Box 9 as 9,477. Mr. Bhatt was granted 17,000 exercisable shares on February 19, 2021. Therefore, the figure reported in Table II, Box 9 following the originally reported transaction should have been 13,727.